File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations

TitleGenetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations
Authors
KeywordsAntihypertensive drugs
Mendelian randomization
Mental disorders
Issue Date2-Jan-2024
PublisherBioMed Central
Citation
BMC Medicine, 2024, v. 22, n. 1 How to Cite?
Abstract

Background

Mental disorders are among the top causes of disease burden worldwide. Existing evidence regarding the repurposing of antihypertensives for mental disorders treatment is conflicting and cannot establish causation.

Methods

We used Mendelian randomization to assess the effects of angiotensin-converting-enzyme inhibitors (ACEIs), beta blockers (BBs), and calcium channel blockers (CCBs) on risk of bipolar disorder (BD), major depression disorder (MDD), and schizophrenia (SCZ). We used published genetic variants which are in antihypertensive drugs target genes and correspond to systolic blood pressure (SBP) in Europeans and East Asians, and applied them to summary statistics of BD (cases = 41,917; controls = 371,549 in Europeans), MDD (cases = 170,756; controls = 329,443 in Europeans and cases = 15,771; controls = 178,777 in East Asians), and SCZ (cases = 53,386; controls = 77,258 in Europeans and cases = 22,778; controls = 35,362 in East Asians) from the Psychiatric Genomics Consortium. We used inverse variance weighting with MR-Egger, weighted median, weighted mode, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier. We performed gene-specific analysis and utilized various methods to address potential pleiotropy.

Results

After multiple testing correction, genetically proxied ACEIs were associated with an increased risk of SCZ in Europeans (odds ratio (OR) per 5 mmHg lower in SBP 2.10, 95% CI 1.54 to 2.87) and East Asians (OR per 5 mmHg lower in SBP 2.51, 95% CI 1.38 to 4.58). Genetically proxied BBs were not associated with any mental disorders in both populations. Genetically proxied CCBs showed no benefits on mental disorders.

Conclusions

Antihypertensive drugs have no protection for mental disorders but potential harm. Their long-term use among hypertensive patients with, or with high susceptibility to, psychiatric illness needs careful evaluation.


Persistent Identifierhttp://hdl.handle.net/10722/339822
ISSN
2023 Impact Factor: 7.0
2023 SCImago Journal Rankings: 2.711
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorFan, Bohan-
dc.contributor.authorZhao, Jie-
dc.date.accessioned2024-03-11T10:39:33Z-
dc.date.available2024-03-11T10:39:33Z-
dc.date.issued2024-01-02-
dc.identifier.citationBMC Medicine, 2024, v. 22, n. 1-
dc.identifier.issn1741-7015-
dc.identifier.urihttp://hdl.handle.net/10722/339822-
dc.description.abstract<h3>Background</h3><p>Mental disorders are among the top causes of disease burden worldwide. Existing evidence regarding the repurposing of antihypertensives for mental disorders treatment is conflicting and cannot establish causation.</p><h3>Methods</h3><p>We used Mendelian randomization to assess the effects of angiotensin-converting-enzyme inhibitors (ACEIs), beta blockers (BBs), and calcium channel blockers (CCBs) on risk of bipolar disorder (BD), major depression disorder (MDD), and schizophrenia (SCZ). We used published genetic variants which are in antihypertensive drugs target genes and correspond to systolic blood pressure (SBP) in Europeans and East Asians, and applied them to summary statistics of BD (cases = 41,917; controls = 371,549 in Europeans), MDD (cases = 170,756; controls = 329,443 in Europeans and cases = 15,771; controls = 178,777 in East Asians), and SCZ (cases = 53,386; controls = 77,258 in Europeans and cases = 22,778; controls = 35,362 in East Asians) from the Psychiatric Genomics Consortium. We used inverse variance weighting with MR-Egger, weighted median, weighted mode, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier. We performed gene-specific analysis and utilized various methods to address potential pleiotropy.</p><h3>Results</h3><p>After multiple testing correction, genetically proxied ACEIs were associated with an increased risk of SCZ in Europeans (odds ratio (OR) per 5 mmHg lower in SBP 2.10, 95% CI 1.54 to 2.87) and East Asians (OR per 5 mmHg lower in SBP 2.51, 95% CI 1.38 to 4.58). Genetically proxied BBs were not associated with any mental disorders in both populations. Genetically proxied CCBs showed no benefits on mental disorders.</p><h3>Conclusions</h3><p>Antihypertensive drugs have no protection for mental disorders but potential harm. Their long-term use among hypertensive patients with, or with high susceptibility to, psychiatric illness needs careful evaluation.</p>-
dc.languageeng-
dc.publisherBioMed Central-
dc.relation.ispartofBMC Medicine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAntihypertensive drugs-
dc.subjectMendelian randomization-
dc.subjectMental disorders-
dc.titleGenetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations-
dc.typeArticle-
dc.identifier.doi10.1186/s12916-023-03218-6-
dc.identifier.scopuseid_2-s2.0-85181233327-
dc.identifier.volume22-
dc.identifier.issue1-
dc.identifier.eissn1741-7015-
dc.identifier.isiWOS:001138091900001-
dc.identifier.issnl1741-7015-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats